Cradle Genomics

company

About

Cradle Genomics is a creator of a novel prenatal testing methodology

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$17.10M
Industries
Biotechnology
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

At Cradle Genomics, their mission is to provide knowledge that helps every pregnancy. They're dedicated to the transformation of non-invasive prenatal testing (NIPT) by offering the most comprehensive fetal genetic analysis and pregnancy health screening solutions at the earliest stages of pregnancy.
Cradle Genomics is newly formed with their headquarters based in San Diego and additional R&D operations located in Detroit. Cradle tests are based on the genetic analysis of fetal cells that are quickly collected during a first trimester visit with no risk to the mother or developing fetus.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$17.10M
Cradle Genomics has raised a total of $17.10M in funding over 2 rounds. Their latest funding was raised on Jul 16, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 16, 2019 Series A $17.10M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Cradle Genomics is funded by 2 investors. Axon Ventures and Listwin Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Axon Ventures Series A
Listwin Ventures Series A